B Cell dysfunction in tumor-draining lymph nodes predicts relapse in oral squamous cell carcinoma
Cancer Immunology, Immunotherapy · 12.11.2025 · 74 (12)
DOI: 10.1007/s00262-025-04231-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 12.11.2025. Verfasst von Vilma Liljeström und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Mouth Neoplasms, Lymph Nodes, Neoplasm Recurrence, Local, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ALF Region Stockholm, Cancerfonden, Radiumhemmets Forskningsfonder.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) presents a persistent clinical challenge, with high recurrence rates and limited improvements in survival despite therapeutic advances. Tumor-draining lymph nodes (TDLNs) are key immunological sites where anti-tumor responses are orchestrated, yet the prognostic relevance of B cell phenotypes in TDLNs remains underexplored. TDLNs from 49 OSCC patients treated at Karolinska University Hospital were prospectively analyzed. Single-cell suspensions were examined using multicolor flow cytometry to characterize B cell subsets (naïve, memory, plasma cells) and expression of immunoregulatory markers (CD11c, CD24, CXCR5, CD73, HLA-DR, PD-L1). B cell profiles were correlated with clinical outcomes, including disease-free survival (DFS) and overall survival (OS). Disease-free patients exhibited a distinct B cell profile marked by a higher proportion of naïve B cells, strong CXCR5 and CD11c expression, and increased plasma cell differentiation. Recurrence was associated with elevated CD24, CD73, and HLA-DR expression, markers linked to immunoregulatory or dysfunctional B cell states. Interestingly, high PD-L1 expression on memory B cells correlated with improved prognosis, suggesting a context-dependent immune function. In line with these observations, multivariate analysis confirmed HLA-DR expression, together with nodal status, as independent prognostic factors for survival in OSCC. B cell phenotypes in OSCC TDLNs are strongly associated with patient outcomes. A microenvironment enriched in naïve and functionally active B cells supports durable tumor control, whereas regulatory/exhausted phenotypes are linked to recurrence. These findings position B cell markers as promising prognostic indicators and therapeutic targets in OSCC, warranting validation in larger cohorts and functional studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
- Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
- Medical Unit Head Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden.
- Department of Surgical Sciences, Section of Otolaryngology and Head and Neck Surgery, Uppsala University, Uppsala, Sweden.
- Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden.
- Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. krzysztof.piersiala@ki.se.
Förderung
- ALF Region Stockholm
- Cancerfonden
- Radiumhemmets Forskningsfonder
- Vetenskapsrådet
- Center for Innovative Medicine
- Karolinska Institute
Zitieren
APA
Liljeström, V., Farrajota Neves da Silva, P., Bark, R., Elliot, A., Marklund, L., Margolin, G., Kumlien Georén, S., Cardell, L. O., & Piersiala, K. (2025). B Cell dysfunction in tumor-draining lymph nodes predicts relapse in oral squamous cell carcinoma. Cancer Immunology, Immunotherapy, 74(12). https://doi.org/10.1007/s00262-025-04231-9
Vancouver
Liljeström V, Farrajota Neves da Silva P, Bark R, Elliot A, Marklund L, Margolin G, et al. B Cell dysfunction in tumor-draining lymph nodes predicts relapse in oral squamous cell carcinoma. Cancer Immunology, Immunotherapy. 2025;74(12). doi:10.1007/s00262-025-04231-9
BibTeX
@article{Liljestrm2025,
author = {Liljeström, Vilma and Farrajota Neves da Silva, Pedro and Bark, Rusana and Elliot, Alexandra and Marklund, Linda and Margolin, Gregori and Kumlien Georén, Susanna and Cardell, Lars-Olaf and Piersiala, Krzysztof},
title = {B Cell dysfunction in tumor-draining lymph nodes predicts relapse in oral squamous cell carcinoma},
journal = {Cancer Immunology, Immunotherapy},
year = {2025},
volume = {74},
number = {12},
doi = {10.1007/s00262-025-04231-9}
}
EUVIMED